{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-23-007471","form_type":"8-K","ticker":"MAIA","cik":"0001878313","company_name":"MAIA Biotechnology, Inc.","filed_at":"2023-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.434171+00:00","generated_at":"2026-06-14T12:05:08.028700+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"MAIA Biotechnology stockholders re-elect directors, ratify auditor, approve equity plan amendment","bullets":["Re-elected Class I directors Louie Ngar Yee and Steven Chaouki with >6M votes each; 352k broker non-votes.","Ratified Grant Thornton as independent auditor for FY2023: 6,502,742 for, 3,091 against, 63 abstain.","Approved amendment to 2021 Equity Incentive Plan allowing annual share increase of 10% of fully diluted outstanding through 2032."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-23-007471","json":"https://secwatch.observer/filing/0001564590-23-007471.json","markdown":"https://secwatch.observer/filing/0001564590-23-007471.md","text":"https://secwatch.observer/filing/0001564590-23-007471.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1878313/000156459023007471/0001564590-23-007471-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1878313/000156459023007471/maia-8k_20230525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T12:05:08.028700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7b95392804d752d7bea014e15544ba657390c175","claim":"MAIA Biotechnology, Inc. shareholders approved Election of Class I directors for three-year terms expiring in 2026 at the 2023-05-25 meeting.","evidence_excerpt":"Stockholders re-elected both of the Company’s Class I nominees for director for three-year terms expiring on the annual meeting of stockholders to be held in 2026 or until their successors are duly elected and qualified","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1878313/000156459023007471/0001564590-23-007471-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"d0e5f228ba934c56e5243c87867cd8b723e8d47d","claim":"MAIA Biotechnology, Inc. shareholders approved Ratification of appointment of Grant Thornton LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-05-25 meeting.","evidence_excerpt":"Stockholders ratified the appointment of Grant Thornton LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1878313/000156459023007471/0001564590-23-007471-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"ef8e8e59fb134e2fc58accf30a6ba9eb7532eb99","claim":"MAIA Biotechnology, Inc. shareholders approved Amendment to the MAIA Biotechnology, Inc. 2021 Equity Incentive Plan to include automatic annual increase in shares reserved at the 2023-05-25 meeting.","evidence_excerpt":"Stockholders approved an amendment to the MAIA Biotechnology, Inc. 2021 Equity Incentive Plan (the “2021 Plan” ) to include an automatic increase in the aggregate number of shares reserved for awards under the 2021 Plan","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1878313/000156459023007471/0001564590-23-007471-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}